Beauty Health (NASDAQ:SKIN – Get Rating) had its price target reduced by Canaccord Genuity Group from $22.00 to $20.00 in a research note issued to investors on Thursday morning, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock.
Other equities research analysts have also recently issued reports about the company. Benchmark lifted their price objective on Beauty Health from $18.00 to $23.00 and gave the stock a buy rating in a research note on Monday, March 14th. Piper Sandler decreased their target price on Beauty Health from $26.00 to $24.00 in a research note on Wednesday, May 11th. JPMorgan Chase & Co. began coverage on Beauty Health in a research note on Friday, March 11th. They issued an overweight rating and a $24.00 target price for the company. Canaccord Genuity Group decreased their target price on Beauty Health from $27.00 to $22.00 in a research note on Wednesday, May 11th. Finally, DA Davidson decreased their target price on Beauty Health from $35.00 to $24.00 in a research note on Wednesday, May 11th. One research analyst has rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, Beauty Health currently has an average rating of Moderate Buy and an average target price of $24.70.
Shares of Beauty Health stock opened at $12.87 on Thursday. The company has a quick ratio of 13.57, a current ratio of 14.25 and a debt-to-equity ratio of 2.14. Beauty Health has a 12 month low of $9.94 and a 12 month high of $30.17. The business has a fifty day simple moving average of $12.77 and a 200 day simple moving average of $15.55. The stock has a market cap of $1.93 billion, a PE ratio of -3.79 and a beta of 1.66.
Several institutional investors have recently modified their holdings of the company. Bank of America Corp DE lifted its holdings in shares of Beauty Health by 4.9% in the first quarter. Bank of America Corp DE now owns 184,257 shares of the company’s stock valued at $3,111,000 after purchasing an additional 8,582 shares in the last quarter. Verition Fund Management LLC bought a new stake in shares of Beauty Health in the first quarter valued at about $598,000. Advisory Services Network LLC bought a new stake in shares of Beauty Health in the first quarter valued at about $308,000. Point72 Hong Kong Ltd bought a new stake in shares of Beauty Health in the first quarter valued at about $189,000. Finally, Prospect Capital Advisors LLC lifted its holdings in shares of Beauty Health by 11.0% in the first quarter. Prospect Capital Advisors LLC now owns 256,200 shares of the company’s stock valued at $4,325,000 after purchasing an additional 25,450 shares in the last quarter. Institutional investors own 72.01% of the company’s stock.
About Beauty Health (Get Rating)
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
- Get a free copy of the StockNews.com research report on Beauty Health (SKIN)
- Schnitzer Steel Witnesses A Strong Quarter On The Back Of Strong Domestic Demand
- MarketBeat: Week in Review 6/27 – 7/1
- Accolade Moves Higher But Growth Is Slowing
- ZIM Integrated Shipping Services (ZIM): Don’t Miss This Dividend
- RH Gives Good Reason To Get Defensive
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.